ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : ÀûÀÀÁõº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° - ½ÃÀå ¿¹Ãø(2025-2034³â)
Paracetamol IV Market Size, Share, Trends, Industry Analysis Report: By Indication (Pain and Pyrexia), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034
»óǰÄÚµå : 1625408
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 128 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 6,001,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,413,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,825,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 11¾ï 1,785¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀº È¿°úÀûÀÎ ÅëÁõ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡À̸ç, ƯÈ÷ ºü¸¥ ¹ßº´ÀÌ Áß¿äÇÑ ÀÓ»ó ÇöÀå¿¡¼­ÀÇ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ °æ±¸Åõ¿©°¡ ¾î·Á¿î ȯÀÚµéÀº °æ±¸Åõ¿©º¸´Ù Á¤¸ÆÅõ¿© Á¦Á¦¸¦ ¼±È£Çϰí ÀÖ¾î ½ÃÀå ¼ö¿ä¸¦ Å©°Ô µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¼ö¼úÀÇ Áõ°¡, ¼ö¼ú ÈÄ ÅëÁõ ¿ÏÈ­¸¦ ÇÊ¿ä·Î ÇÏ´Â ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ÀÇ Áõ°¡ µîÀÇ ¿äÀÎÀÌ ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ÀÇ·á ÀÎÇÁ¶ó°¡ È®´ëµÇ¸é¼­ ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀåÀÇ ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀåÀÇ Àü¸ÁÀº ºÐ¸í ¹àÀ¸¸ç, ¾à¹°Àü´ÞÀÇ È¹±âÀûÀÎ ±â¼ú Çõ½Å°ú ´Ù¾çÇÑ È¯ÀÚ±º¿¡ ´ëÇÑ ÆÄ¶ó¼¼Å¸¸ôÀÇ Á¤¸Æ Åõ¿©°¡ º¸´Ù ¾ÈÀüÇϰí È¿°úÀûÀÏ ¼ö ÀÖµµ·Ï ÇÏ´Â Á¦Çü ±â¼úÀÇ ¹ßÀüÀº Å« ½ÃÀå ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀåÀÇ È®´ë´Â ¾÷°è ¼±µÎÁÖÀÚµéÀÇ Àü·«Àû R&D ÅõÀÚ¿¡ ÀÇÇØ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅõÀÚ´Â ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­Çϸ鼭 Á¦Ç°ÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» ±Ø´ëÈ­ÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß°í ÀÖÀ¸¸ç, ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç Á¦Á¦°¡ ÅëÁõ °ü¸® ÇÁ·ÎÅäÄÝ¿¡¼­ ´õ ³ªÀº ¼±ÅÃÀÌ µÉ ¼ö ÀÖ´Â ±â¹ÝÀ» ¸¶·ÃÇϰí ÀÖ½À´Ï´Ù.

ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

2024³â ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀåÀº ¼ö¼ú ÈÄ ¶Ç´Â ¿Ü»ó ÈÄ È¿°úÀûÀ̰í Áï°¢ÀûÀÎ ÁøÅë¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä·Î ÀÎÇØ ÀûÀÀÁõº°·Î´Â ÅëÁõ ºÐ¾ß°¡ Å« ºñÁßÀ» Â÷ÁöÇß½À´Ï´Ù.

¿Ü·¡ Áø·á¿¡ ´ëÇÑ ¼±È£µµ°¡ Áõ°¡Çϰí Ŭ¸®´Ð¿¡¼­ Á¤¸Æ ³» ÅëÁõ °ü¸® ¿É¼ÇÀÇ °¡¿ë¼ºÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÃÖÁ¾ »ç¿ë ±â¹Ý Ŭ¸®´Ð ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2024³â ±âÁØ ºÏ¹Ì°¡ ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀå Á¡À¯À²À» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ÀÌ´Â ÀÌ Áö¿ª Àüü¿¡¼­ È¿°úÀûÀÎ ÅëÁõ °ü¸®¿¡ ´ëÇÑ Á߿伺ÀÌ °­Á¶µÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº ÇコÄɾî ÅõÀÚ Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ÁÖ¿ä ½ÃÀå ±â¾÷À¸·Î´Â Mallinckrodt(Mallinckrodt Pharmaceuticals), Cipla Inc. Pharmaceutical Industries Limited, Novartis AG, Pfizer Inc., Abbott, Sanofi, Bristol-Myers Squibb Company µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀå : ÀûÀÀÁõº°

Á¦6Àå ¼¼°èÀÇ ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀå : ¿ëµµº°

Á¦7Àå ¼¼°èÀÇ ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ ÆÄ¶ó¼¼Å¸¸ô Á¤¸ÆÁÖ»ç ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The paracetamol IV market size is expected to reach USD 1,117.85 million by 2034, according to a new study by Polaris Market Research. The report "Paracetamol IV Market Share, Size, Trends, Industry Analysis Report: By Indication (Pain and Pyrexia), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising demand for effective pain management solutions, particularly in clinical settings where rapid onset is crucial, drives the paracetamol IV market expansion. The preference for intravenous (IV) formulations over oral routes, especially for patients unable to take medication orally, significantly supports market demand. Factors such as increasing surgical procedures, a growing prevalence of chronic conditions requiring postoperative pain relief, and the expanding geriatric population contribute to the rising need for paracetamol IV formulations. The global expansion of healthcare infrastructure is significantly propelling the paracetamol IV market growth, as more hospitals and clinics are becoming equipped to provide IV pain management.

The paracetamol IV market outlook is undeniably positive, with significant market opportunities fueled by groundbreaking innovations in drug delivery and enhanced formulation techniques that ensure intravenous (IV) paracetamol is both safer and more effective for diverse patient groups. Furthermore, the IV paracetamol market expansion is supported by strategic investments in research and development from leading industry players. These investments are specifically geared toward maximizing product efficacy and safety while minimizing side effects, firmly establishing IV paracetamol as a better option in pain management protocols.

Paracetamol IV Market Report Highlights

In terms of indication, in 2024, the pain segment accounted for a larger share of the paracetamol IV market revenue due to the high demand for effective and immediate pain relief in post-surgical and trauma cases.

The clinics segment, based on end use, is expected to witness the highest CAGR during the forecast period due to the growing preference for outpatient care and the increasing availability of intravenous pain management options in clinic settings.

In 2024, North America dominated the paracetamol IV market share due to the strong focus on effective pain management practices across the region.

The Asia Pacific market is expected to witness significant growth during the forecast period due to increasing healthcare investments.

A few global key market players are Mallinckrodt (Mallinckrodt Pharmaceuticals), Cipla Inc., Lupin, Dr Reddy's Laboratories Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Limited, Novartis AG, Pfizer Inc., Abbott, Sanofi, and Bristol-Myers Squibb Company.

Polaris Market Research has segmented the paracetamol IV market report on the basis of indication, application, end use, and region:

By Indication Outlook (Revenue, USD Million; 2020-2034)

By Application Outlook (Revenue, USD Million; 2020-2034)

By End Use Outlook (Revenue, USD Million; 2020-2034)

By Regional Outlook (Revenue, USD Million; 2020-2034)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Paracetamol IV Market Insights

5. Global Paracetamol IV Market, by Indication

6. Global Paracetamol IV Market, by Application

7. Global Paracetamol IV Market, by End Use

8. Global Paracetamol IV Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â